FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma Indicated for newly diagnosed patients who are eligible for stem cell transplant Jul 31, 2024
Heavy Metal in Chocolate; Trump 'No Doubt' Hit By Bullet; FDA Cinnamon Warning Grows Health news and commentary gathered by app staff Jul 31, 2024
Alzheimer's Gets New Galantamine Drug Newly approved prodrug has dual mechanism of action to improve tolerability Jul 30, 2024
FDA Warns of Overdoses With Compounded Semaglutide Multi-dose vials pose complications for self-administration Jul 29, 2024
New Monthly Paliperidone Palmitate Injectable OK'd for Schizophrenia Long-acting intramuscular product approved for schizoaffective disorder as well Jul 29, 2024
FDA Approves Blood Test for Colon Cancer Screening Shield becomes the first liquid biopsy for primary CRC screening Jul 29, 2024
Veterans Lobby for Psychedelic Therapy, but Will It Influence MDMA's Approval? Hurdles remain for FDA application Jul 27, 2024
Third JAK Inhibitor for Alopecia Areata Wins FDA Approval Over 30% of patients had at least 80% scalp hair regrowth with deuruxolitinib Jul 26, 2024
FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials Committee unanimously backs mandating trial design to distinguish effects of therapy phases Jul 25, 2024
'Shambolic' Medical Meeting; DaVita Whistleblower Suit; FDA Mum on MDMA This past week in healthcare investigations Jul 24, 2024
FDA OKs First Orally Dissolving Birth Control Pill Opens up options for people who have trouble swallowing Jul 24, 2024
Trump Talks Cancer Cures, 'Right to Try' as He Accepts GOP Presidential Nomination "We're going to get to the bottom of it" Jul 19, 2024
FDA Allows Best-Selling E-Cigarette Vuse Alto, but Only in Tobacco Flavor Agency previously rejected the company's menthol-flavored products Jul 18, 2024
Anti-VEGF Ocular Implant for Age-Related Macular Degeneration to Return to Market Updates to device, refill syringe, manufacturing process restore function to expected level Jul 08, 2024
With the End of Chevron, Health and Environmental Experts' Hands Are Tied We need the rule of law to protect public health Jul 08, 2024
Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases? U.S. clinics market oligonucleotide therapy for a wide range of conditions, without much evidence Jul 05, 2024
Supreme Court to Weigh if FDA Was Heavy-Handed With Its Flavored E-Cig Regulations Agency is appealing a lower court ruling siding with vaping companies Jul 03, 2024
FDA OKs Another Drug for Early Alzheimer's Disease Decision gives patients a second anti-amyloid treatment option Jul 02, 2024
Supreme Court Decision May Have Sweeping Effects on Healthcare, Experts Say Chevron ruling curbs federal power, could upend drug approvals, Medicare drug price negotiation Jul 02, 2024
House Panel OKs Bills on Obesity Drug and Breakthrough Device Coverage in Medicare Meanwhile, CMS proposed rule on the device coverage, issued a year ago, awaits a final version Jul 01, 2024
FDA OKs First Point-of-Care Test for Detecting Hep C in At-Risk Adults Results as quick as 1 hour, enabling a test-and-treat approach Jun 27, 2024
FDA Warns Eye Bank for Taking Donors Who Had Sepsis All five donors should have been ineligible, FDA said Jun 27, 2024
FDA Approves Novel Nebulized Therapy for COPD First-in-class dual phosphodiesterase inhibitor lands broad indication for COPD maintenance Jun 27, 2024
Oncology Drug Shortages Persist, but Continue to Evolve Supply-chain issues, unrealistically low prices for generics, hoarding, other factors to blame Jun 26, 2024
Docs in Abortion Ban States Find Workarounds to Deliver Care A app survey reveals surprising trends in reproductive care 2 years post-Roe Jun 24, 2024
Subcutaneous C5 Inhibitor Approved for PNH Longer-acting crovalimab designed for more sustained effect and less treatment burden Jun 24, 2024
New Treatment Approved for Chronic Inflammatory Demyelinating Polyneuropathy Efgartigimod injection reduced CIDP relapse risk Jun 23, 2024
Adagrasib Wins Accelerated Approval for KRAS-Mutant Colorectal Cancer KRAS inhibitor plus cetuximab achieved 34% response rate, 85% disease control in early trial Jun 21, 2024
FDA Authorizes First Menthol E-Cigarettes Meanwhile, HHS still has not issued a final rule banning menthol-flavored tobacco cigarettes Jun 21, 2024
FDA Warns Yet Another Birth Tissue Company Agency says Neobiosis amniotic fluid, umbilical cord products should be regulated as drugs Jun 21, 2024
Gene Therapy for Duchenne Muscular Dystrophy Gets Expanded Approval Primary endpoint wasn't met, but other outcomes provided "substantial evidence of effectiveness" Jun 21, 2024
FDA Plans to Ease Requirements for Biosimilars' Interchangeable Status New rules would mean switching studies will generally not be needed Jun 20, 2024
Topical Agent for Hyperhidrosis Wins FDA Approval Sofpironium gel meets all primary and secondary endpoints in two vehicle-controlled trials Jun 20, 2024
Drug Shortages Keep Growing. Older, Injectable Agents Are Among the Most Vulnerable. A Q&A with Erin Fox, PharmD, MHA, on the record-breaking shortages Jun 19, 2024
FDA Approves Pneumococcal Vax Designed Specifically for Adults Covers serotypes responsible for over 80% of invasive pneumococcal disease in those 50 and up Jun 18, 2024
Two New Immunotherapy-Chemo Options Approved for Endometrial Cancer New indications for pembrolizumab and durvalumab in advanced disease Jun 17, 2024
Some Hawking Stem Cells Say They Can Treat Almost Anything. They Can't. Attorneys general in several states have sued businesses for false claims Jun 17, 2024
Secret Pentagon Anti-Vax Campaign; FDA's Tylenol Warning; E. Coli at the Olympics Health news and commentary gathered by app staff Jun 17, 2024
The Next Big Challenges for Medication Abortion Anti-abortion states continue to fight; a possible Trump victory opens door to new strategies Jun 14, 2024